First Trust Advisors
DCPH

First Trust Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

First Trust Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-71,501
Closed -$1.01M – 2522
2023
Q2 		$1.01M Buy
+71,501
New +$1.02M ﹤0.01% 1984
2022
Q2 		– Sell
-41,192
Closed -$382K – 2640
2022
Q1 		$382K Buy
41,192
+26,408
+179% +$225K ﹤0.01% 2323
2021
Q4 		$144K Buy
+14,784
New +$278K ﹤0.01% 2485

Other funds holding DCPH

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Trust Advisors's DCPH Position: Q3 2023 in Review

First Trust Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2023, closing a stake of 71,501 shares — an estimated $1.01M sold.

First Trust Advisors first reported a position in DCPH in Q4 2021 and held it in 3 quarters. The position peaked at $1.01M in Q2 2023. 157 funds tracked by Wall St. Rank hold DCPH as of Q3 2023.

  • First Trust Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • First Trust Advisors sold 71,501 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2023, an estimated $1.01M.
  • First Trust Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • First Trust Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.01M in Q2 2023.
  • 157 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2023.

Based on First Trust Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.